Vaccine News and Research

Latest Vaccine News and Research

Study detects ten avian influenza A viruses in poultry from four provinces in China

Researchers identified 10 avian influenza A(H5N6) viruses in poultry from four Chinese provinces, with immune-evasion and complex genetic recombination potential.

14 Jul 2022

Invasive pneumococcal disease among children during the COVID-19 pandemic in England

Researchers demonstrated heightened invasive pneumococcal disease incidence in children younger than 15 during the SARS-CoV-2 pandemic in England.

14 Jul 2022

Epidemiologic features of the June 2022 monkeypox outbreak in Spain

Researchers described epidemiologic features of monkeypox cases reported in Spain and the intervention measures taken to control the outbreak.

14 Jul 2022

Researchers identify fusion peptide-specific monoclonal antibodies with broad neutralizing activity

Neutralizing mAbs identified in the current study sheds light on ACE2-triggered conformational change that restricts the immunogenicity of the highly conserved FP region.

14 Jul 2022

The global succinylation and protein abundance in SARS-CoV-2–infected cells

Researchers assessed the global succinylation of SARS-CoV-2-infected host cells.

14 Jul 2022

Virtual reality app trial offers new hope for people suffering from phobias

Results from a University of Otago, Christchurch trial suggest fresh hope for the estimated one-in-twelve people worldwide suffering from a fear of flying, needles, heights, spiders and dogs.

14 Jul 2022

SARS-Arena reveals conserved parts of viral proteins that cause COVID-19

Vaccines may need to dig a little deeper to stop SARS-CoV-2. Rice University researchers are providing a new shovel.

14 Jul 2022

Study provides detailed understanding of SARS-CoV-2 Omicron sublineage antibody escape

A new study reveals the antibody-mediated neutralization of both current and emerging Omicron subvariants.

13 Jul 2022

Using microparticles to create 'self-boosting' vaccines

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

13 Jul 2022

Knowledge gaps in product labels make it challenging for healthcare providers to recommend vaccines to pregnant women

Existing gaps and serious limitations concerning the information in vaccine product labels makes it challenging for healthcare providers to know when to recommend vaccination to pregnant women.

13 Jul 2022

Evolutionary characteristics of the SARS-CoV-2 Omicron variant

Researchers compared the mutations in the SARS-CoV-2 Omicron variant with others to highlight their evolutionary differences.

13 Jul 2022

Study suggests ZCB11 as a promising antibody drug against all SARS-CoV-2 variants of concern

Researchers at the AIDS Institute, The University of Hong Kong, Department of Microbiology, School of Clinical Medicine, the LKS Faculty of Medicine of The University of Hong Kong and the State Key Laboratory of Emerging Infectious Diseases, HKU, together with structural biologists at The Hong Kong University of Science and Technology, have demonstrated that ZCB11, a broadly neutralizing antibody derived from a local mRNA-vaccinee against the spreading Omicron variants of SARS-CoV-2, displays potent antiviral activities against all variants of concern (VOCs), including the dominantly spreading Omicron BA.1, BA1.1 and BA.2.

13 Jul 2022

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

In a new study, researchers reported that Pfizer’s BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 does not affect the honeymoon phase of type 1 diabetes (T1D).

13 Jul 2022

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Researchers assessed the efficacy of the novel SARS-CoV-2 doggybone deoxyribonucleic acid (DNA) vaccine.

13 Jul 2022

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Researchers reported a class switch in SARS-CoV-2-specific antibodies due to repeated mRNA vaccinations.

13 Jul 2022

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

People with systemic lupus erythematosus, or SLE, who received a "booster" dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent "breakthrough" COVID-19 infection, a new study shows.

13 Jul 2022

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

A new study reports the production of neutralizing antibodies against SARS-CoV-2 in hyperimmunized hens.

12 Jul 2022

Scientists explore antigenic imprinting in SARS-CoV-2

A recently published study compared monoclonal RBD antibody responses induced by SARS-CoV-2 Beta variant infections to antibodies induced by the ancestral virus in immunologically naive subjects.

12 Jul 2022

AI model detects people's vaccine attitudes from their social media posts

People's attitudes towards vaccines can now be detected from their social media posts by an intelligent AI model, developed by researchers at the University of Warwick.

12 Jul 2022

University of Oxford begins recruiting for Phase I trial of new TB vaccine

The University of Oxford has begun recruiting for a Phase I trial with a tuberculosis vaccine in human volunteers at Oxford to develop a new way to test the efficacy of future TB vaccines - with the first volunteers being challenged today (Wednesday).

12 Jul 2022

Vaccine News and Research

Latest Vaccine News and Research

Study detects ten avian influenza A viruses in poultry from four provinces in China

Invasive pneumococcal disease among children during the COVID-19 pandemic in England

Epidemiologic features of the June 2022 monkeypox outbreak in Spain

Researchers identify fusion peptide-specific monoclonal antibodies with broad neutralizing activity

The global succinylation and protein abundance in SARS-CoV-2–infected cells

Virtual reality app trial offers new hope for people suffering from phobias

SARS-Arena reveals conserved parts of viral proteins that cause COVID-19

Study provides detailed understanding of SARS-CoV-2 Omicron sublineage antibody escape

Using microparticles to create 'self-boosting' vaccines

Knowledge gaps in product labels make it challenging for healthcare providers to recommend vaccines to pregnant women

Evolutionary characteristics of the SARS-CoV-2 Omicron variant

Study suggests ZCB11 as a promising antibody drug against all SARS-CoV-2 variants of concern

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

Scientists explore antigenic imprinting in SARS-CoV-2

AI model detects people's vaccine attitudes from their social media posts

University of Oxford begins recruiting for Phase I trial of new TB vaccine

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in